MEDP
Medpace Holdings, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$619.66
+0.19%Oct 13, 2026, 23:15 UTC
Medpace Holdings, Inc. shares closed at $609.89, down 1.64% from the previous trading session.
Source:Oct 6, 2026, 23:15 UTC
Medpace Holdings, Inc. shares closed at $602.90, down 2.84% from the prior session's close.
Source:Sep 29, 2026, 23:16 UTC
Medpace (MEDP) shares rose 1% to close at $622.11 while the broader market declined.
Source:Sep 22, 2026, 20:05 UTC
Medpace Holdings announced it will report its third quarter 2026 financial results after market close on October 21, 2026, with a conference call the following morning.
Source:Sep 21, 2026, 23:15 UTC
Medpace (MEDP) shares rose 1.94% to close at $624.2 in the recent trading session.
Source:Sep 14, 2026, 23:15 UTC
Medpace (MEDP) shares closed at $595.41, up 1.34% from the previous day, while the broader market fell.
Source:Aug 26, 2026, 17:21 UTC
Medpace reported second-quarter earnings that beat expectations.
Source:Aug 22, 2026, 07:07 UTC
Allworth Financial LP acquired a new stake in Medpace Holdings, Inc. during the second quarter of 2026, purchasing 3,894 shares valued at approximately $2,062,000, as disclosed in a 13F filing.
Source:Aug 20, 2026, 07:13 UTC
Abacus FCF Advisors LLC acquired a new stake in Medpace Holdings, Inc. during the second quarter, purchasing 12,529 shares valued at approximately $6.63 million.
Source:Aug 14, 2026, 03:58 UTC
Medpace Holdings raised its 2026 revenue guidance to a midpoint of $2.85 billion during its second-quarter earnings call.
Source:Aug 10, 2026, 12:23 UTC
Kuehn Law, PLLC announced an investigation into potential breaches of fiduciary duty by officers and directors of Medpace Holdings, Inc., related to a federal securities lawsuit alleging misrepresentation of backlog cancellation rates and business conditions.
Source:Aug 5, 2026, 15:36 UTC
Medpace Holdings reported record bookings and a higher book-to-bill ratio in the second quarter of 2026, reversing the weaker first-quarter trend.
Source:Jul 22, 2026, 20:15 UTC
Medpace Holdings, Inc. announced its financial results for the second quarter ended June 30, 2026, reporting revenue of $707.3 million, a 17.2% increase from the prior-year period.
Jun 4, 2026, 00:00 UTC
Medpace Holdings, Inc. appointed Brad W. Hansman as Executive Vice President, Operations effective June 1, 2026.
Jun 1, 2026, 07:51 UTC
A class action lawsuit was filed against Medpace Holdings, Inc. for securities law violations.